<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>D-151salinesoultionUQ</udiDi>
    <basicUdiDi>B-151salinesoultionUQ</basicUdiDi>
    <tradeName>OPTRA-SAFE</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v - 10 ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>151</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-11T05:47:02.675Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-151salinesolutionU6</udiDi>
    <basicUdiDi>B-151salinesolutionU6</basicUdiDi>
    <tradeName>OPTRA-LIV</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v 10 ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>151</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-11T05:47:01.878Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-151salinesolution10mlLF</udiDi>
    <basicUdiDi>B-151salinesolution10mlLF</basicUdiDi>
    <tradeName>EYE POD-L</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v 10 ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>151</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-11T05:46:57.101Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-150salinesolutionSP</udiDi>
    <basicUdiDi>B-150salinesolutionSP</basicUdiDi>
    <tradeName>OPTRA-LIV</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v 2.5ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>150</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-11T05:38:10.923Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-150eyepodlUX</udiDi>
    <basicUdiDi>B-150eyepodlUX</basicUdiDi>
    <tradeName>EYE POD-L</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v 2.5 ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>150</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-11T05:38:10.126Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-137salinesolutionZN</udiDi>
    <basicUdiDi>B-137salinesolutionZN</basicUdiDi>
    <tradeName>OPTRA-LIV</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v 30 ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>137</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-11T03:07:55.242Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-137salinesolution30mlUZ</udiDi>
    <basicUdiDi>B-137salinesolution30mlUZ</basicUdiDi>
    <tradeName>EYE POD-L</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v 30 ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>137</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-11T03:07:51.239Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-131salinesolutionQU</udiDi>
    <basicUdiDi>B-131salinesolutionQU</basicUdiDi>
    <tradeName>OPTRA-LIV</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v 2 ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>131</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-11T02:58:07.831Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-131salinesolution2mlMV</udiDi>
    <basicUdiDi>B-131salinesolution2mlMV</basicUdiDi>
    <tradeName>EYE POD-L</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v 2 ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>131</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-11T02:58:05.437Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-1300141954</udiDi>
    <basicUdiDi>B-1300141954</basicUdiDi>
    <tradeName>FIDIAL PLUS</tradeName>
    <deviceName>FIDIAL PLUS</deviceName>
    <manufacturerName>Fidia Farmaceutici S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000026988</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>13001419</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-11T02:57:25.398Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-124salinesolutionTL</udiDi>
    <basicUdiDi>B-124salinesolutionTL</basicUdiDi>
    <tradeName>OPTRA-SAFE</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v - 15 ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>124</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-11T02:55:07.605Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-124salinesolution15mlLU</udiDi>
    <basicUdiDi>B-124salinesolution15mlLU</basicUdiDi>
    <tradeName>EYE POD-L</tradeName>
    <deviceName>Sodium Chloride Eyewash Solution 0.9% w/v 15 ml</deviceName>
    <manufacturerName>Legency Remedies Pvt. Ltd.</manufacturerName>
    <manufacturerSrn>IN-MF-000010030</manufacturerSrn>
    <authorisedRepresentativeName>Europecert UG (haftungsbeschränkt)</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000004974</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>124</reference>
    <placedOnMarketCountry>Denmark</placedOnMarketCountry>
    <lastUpdated>2026-07-11T02:55:06.780Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250906200042</udiDi>
    <basicUdiDi>425090620HA-OVDUG</basicUdiDi>
    <tradeName>VisOcu</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PHI141DE-VSO</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-11T01:28:16.113Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250906200059</udiDi>
    <basicUdiDi>425090620HA-OVDUG</basicUdiDi>
    <tradeName>VisOcu</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PHI161DE-VSO</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-07-11T01:28:16.099Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250906200066</udiDi>
    <basicUdiDi>425090620HA-OVDUG</basicUdiDi>
    <tradeName>VisOcu</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PHI181DE-VSO</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-11T01:28:16.079Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250906200073</udiDi>
    <basicUdiDi>425090620HA-OVDUG</basicUdiDi>
    <tradeName>VisOcu</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PHI221DE-VSO</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-07-11T01:28:16.048Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250906200080</udiDi>
    <basicUdiDi>425090620HA-OVDUG</basicUdiDi>
    <tradeName>VisOcu</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PHI301DE-VSO</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-11T01:28:16.019Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250906200110</udiDi>
    <basicUdiDi>425090620HA-OVDUG</basicUdiDi>
    <tradeName>ViscOge</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PHI101DE-VSG</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-11T01:28:15.988Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250906200127</udiDi>
    <basicUdiDi>425090620HA-OVDUG</basicUdiDi>
    <tradeName>ViscOge</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PHI141DE-VSG</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-11T01:28:15.971Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250906200134</udiDi>
    <basicUdiDi>425090620HA-OVDUG</basicUdiDi>
    <tradeName>ViscOge</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PHI161DE-VSG</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-11T01:28:15.957Z</lastUpdated>
  </row>
</eudamedExport>